Nexstim Oyj (STU:5NX) Total Current Assets: €9.50 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:5NX Nexstim Oyj STU:5NX
61 GF Score
Price €9.45
GF Value €8.18
! 5 Warning Signs
View Full Analysis

What is Nexstim Oyj Total Current Assets?

Nexstim Oyj STU:5NX -3.37% 61 Total Current Assets is €9.50 Mil as of Jun. 2026. GuruFocus rates STU:5NX with a GF Score™ of 61/100 and a GF Value™ of €8.18. The stock has 5 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Nexstim Oyj's total current assets for the quarter that ended in Jun. 2026 was €9.50 Mil.


Nexstim Oyj  (STU:5NX) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Nexstim Oyj's Liquidation Value for the quarter that ended in Jun. 2026 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=5.592-8.028+0.75 * 2.477+0.5 * 0.759
=-0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nexstim Oyj Total Current Assets Related Terms


Nexstim Oyj Total Current Assets Historical Data

* Premium members only.

The historical data trend for Nexstim Oyj's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexstim Oyj Total Current Assets Chart

Nexstim Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.03 7.26 5.94 9.04 7.47

Nexstim Oyj Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.67 9.04 6.89 7.47 9.50
STU:5NX
61GF Score
Nexstim Oyj STU:5NX
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nexstim Oyj Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Nexstim Oyj's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Nexstim Oyj's Total Current Assets for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of €9.50 Mil mean?
Nexstim Oyj (STU:5NX) has a Total Current Assets of €9.50 Mil as of Jun. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Nexstim Oyj and its competitors.
Is Nexstim Oyj's Total Current Assets too high?
Nexstim Oyj's current Total Current Assets is €9.50 Mil. Overall, Nexstim Oyj has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Nexstim Oyj's Total Current Assets compare to ABT and SYK?
Nexstim Oyj's Total Current Assets of €9.50 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Medical Devices & Instruments company?
A good Total Current Assets depends on the Medical Devices & Instruments industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Nexstim Oyj and its competitors. Nexstim Oyj's current Total Current Assets is €9.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexstim Oyj stock overvalued right now?
Nexstim Oyj (STU:5NX) has a current Total Current Assets of €9.50 Mil. The stock's GF Value™ is €8.18, compared to a current price of €9.45 — trading 15.5% above its estimated fair value. The current Total Current Assets is €9.50 Mil. Nexstim Oyj's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Nexstim Oyj (STU:5NX), the current Total Current Assets is €9.50 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nexstim Oyj (STU:5NX) Overvalued in 2026?

Based on GuruFocus' analysis, Nexstim Oyj stock appears to be overvalued. The current stock price of €9.45 is trading 15.5% above its estimated GF Value™ of €8.18.

Key valuation signals for STU:5NX:

  • Total Current Assets: €9.50 Mil
  • GF Value™: €8.18 vs. price of €9.45 (15.5% above fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the STU:5NX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nexstim Oyj Business Description

Other Exchanges NXTMH:Finland5NX:Germany
Address Elimaenkatu 9 B, Helsinki, FIN, 00510
Nexstim Oyj is a Finnish medical technology company. It has developed a non-invasive brain-stimulation technology for navigated transcranial magnetic stimulation (nTMS), with sophisticated 3D navigation that provides accurate, personalized targeting of TMS to specific brain areas. The company's diagnostic business focuses on commercializing the NBS System 6, an FDA-cleared, CE-marked navigated TMS system for pre-surgical mapping of the brain's speech and motor cortices. Its therapy business sells the NBS System 6 for the treatment of depressive disorder in the United States, and for the treatment of depression, chronic neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb, in Europe. Geographically, the firm generates maximum revenue from North America.
61GF Score

Get the complete analysis for STU:5NX

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.45
Price
€8.18
GF Value